Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002155
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Six-Month Safety and Antiviral Study in HIV-1 Seropositive AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cellsmm3 to Evaluate MK-639 Alone Versus Zidovudine AZT and 3TC Versus the Combination of MK-639 With AZT3TC
Sponsor:
Merck Sharp Dohme LLC
Organization:
NIH AIDS Clinical Trials Information Service
Organization Data
Organization:
NIH AIDS Clinical Trials Information Service
Class:
INDUSTRY
Study ID:
246E
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merck Sharp Dohme LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None